NASDAQ:IART appears to be flying under the radar despite its strong fundamentals.

Our stock screening tool has identified INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) as an undervalued gem with strong fundamentals. NASDAQ:IART boasts decent financial health and profitability while maintaining an attractive price point. We'll break it down further.

Evaluating Valuation: NASDAQ:IART

An integral part of ChartMill's stock analysis is the Valuation Rating, which spans from 0 to 10. This rating evaluates diverse valuation factors, including price to earnings and cash flows, while considering the stock's profitability and growth. NASDAQ:IART has received a 7 out of 10:

• A Price/Earnings ratio of 10.53 indicates a reasonable valuation of IART.
• Based on the Price/Earnings ratio, IART is valued cheaper than 96.86% of the companies in the same industry.
• IART's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.19.
• IART is valuated reasonably with a Price/Forward Earnings ratio of 9.05.
• Compared to the rest of the industry, the Price/Forward Earnings ratio of IART indicates a rather cheap valuation: IART is cheaper than 97.91% of the companies listed in the same industry.
• When comparing the Price/Forward Earnings ratio of IART to the average of the S&P500 Index (19.98), we can say IART is valued rather cheaply.
• 94.24% of the companies in the same industry are more expensive than IART, based on the Enterprise Value to EBITDA ratio.
• Based on the Price/Free Cash Flow ratio, IART is valued cheaper than 81.68% of the companies in the same industry.
• IART has a very decent profitability rating, which may justify a higher PE ratio.

Looking at the Profitability

ChartMill assigns a proprietary Profitability Rating to each stock. The score is computed by evaluating various profitability ratios and margins and ranges from 0 to 10. NASDAQ:IART was assigned a score of 7 for profitability:

• IART has a better Return On Assets (0.99%) than 73.82% of its industry peers.
• IART has a better Return On Equity (2.52%) than 74.87% of its industry peers.
• With a decent Return On Invested Capital value of 5.15%, IART is doing good in the industry, outperforming 77.49% of the companies in the same industry.
• IART's Profit Margin of 2.63% is fine compared to the rest of the industry. IART outperforms 73.30% of its industry peers.
• With an excellent Operating Margin value of 15.14%, IART belongs to the best of the industry, outperforming 86.39% of the companies in the same industry.
• IART's Operating Margin has improved in the last couple of years.

Evaluating Health: NASDAQ:IART

ChartMill employs a unique Health Rating system for all stocks. This rating, ranging from 0 to 10, is determined by analyzing various liquidity and solvency ratios. For NASDAQ:IART, the assigned 5 for health provides valuable insights:

• With a decent Debt to FCF ratio value of 30.49, IART is doing good in the industry, outperforming 68.59% of the companies in the same industry.
• A Current Ratio of 4.68 indicates that IART has no problem at all paying its short term obligations.
• With a decent Current ratio value of 4.68, IART is doing good in the industry, outperforming 67.54% of the companies in the same industry.
• IART has a Quick Ratio of 3.35. This indicates that IART is financially healthy and has no problem in meeting its short term obligations.
• With a decent Quick ratio value of 3.35, IART is doing good in the industry, outperforming 63.87% of the companies in the same industry.

Assessing Growth Metrics for NASDAQ:IART

To evaluate a stock's growth potential, ChartMill utilizes a Growth Rating on a scale of 0 to 10. This comprehensive assessment considers various growth aspects, including historical and estimated EPS and revenue growth. NASDAQ:IART has achieved a 4 out of 10:

• Based on estimates for the next years, IART will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.76% on average per year.
• The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
• The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

Our Decent Value screener lists more Decent Value stocks and is updated daily.

Our latest full fundamental report of IART contains the most current fundamental analsysis.

Disclaimer

This article should in no way be interpreted as advice. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.